• Serotonin Inhibits HRP-Based Proximity Labeling: Mechanisms

  2026-07-15

  This study uncovers a previously unrecognized inhibition of HRP-mediated protein biotinylation by serotonin, a key neurotransmitter, using biotin-LC-LC-tyramide (Biotin-XX Tyramide Reagent). The authors demonstrate a specific, reversible mechanism of interference, informing future proteomic mapping efforts in serotonergic systems and offering practical mitigation strategies for neuroscience research.

• EPI-001: Advanced Androgen Receptor N-Terminal Domain Inhibi

  2026-07-14

  EPI-001 stands out as a potent androgen receptor N-terminal domain inhibitor, uniquely disrupting both ligand-dependent and independent signaling. This guide translates recent mechanistic discoveries into optimized experimental protocols for prostate and breast cancer research, with actionable troubleshooting and workflow enhancements.

• Bufalin Directly Targets STK33 in Triple-Negative Breast Can

  2026-07-14

  The referenced study establishes serine/threonine kinase 33 (STK33) as a direct molecular target of Bufalin in triple-negative breast cancer (TNBC). By elucidating Bufalin’s mechanism in degrading STK33 and suppressing TNBC progression, the findings provide a foundation for targeted therapeutic strategies and assay development in oncology research.

• Novobiocin in Antiviral and Antiparasitic Assays: Mechanisti

  2026-07-13

  Explore Novobiocin, an aminocoumarin antibiotic, as a cross-domain tool in antiviral and antiparasitic research. This article delivers rigorous scientific insight into its unique mechanisms, supported by recent in vitro findings, and guides advanced assay design beyond standard antibacterial workflows.

• AEBSF.HCl in Protease Pathways: Translational Leverage for N

  2026-07-13

  This thought-leadership article explores how AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) provides unique strategic advantages for translational researchers investigating serine protease pathways in necroptosis and amyloid precursor protein processing. By integrating mechanistic insights from recent discoveries—such as the role of lysosomal membrane permeabilization and cathepsin B in cell fate decisions—this guide highlights how AEBSF.HCl advances experimental control beyond conventional inhibitor paradigms, offering actionable guidance on protocol design, cross-disease modeling, and translational relevance.

• Antipyrine (B1886): Reliable Benchmark for CNS Assays

  2026-07-12

  This article explores the validated utility of Antipyrine (SKU B1886) as a benchmark compound in blood-brain barrier, pain, and fever research. Through scenario-driven, evidence-based Q&A, we address common lab challenges and illustrate how Antipyrine's high solubility and purity underpin reproducible pharmacokinetic and cytotoxicity assays in the life sciences.

• O-GlcNAcylation Drives Wnt-Induced Bone Formation via Glycol

  2026-07-10

  This study reveals that O-GlcNAcylation is essential for Wnt3a-driven bone formation by rewiring aerobic glycolysis in osteoblasts. By mechanistically linking Wnt signaling, O-GlcNAcylation, and metabolic control, it advances our understanding of osteogenesis and opens new avenues for precision modulation in bone disease models.

• HOBt (1-Hydroxybenzotriazole): Precision in Amide Bond Forma

  2026-07-09

  HOBt (1-Hydroxybenzotriazole) revolutionizes peptide and amide synthesis by minimizing epimerization and enhancing coupling efficiency, even with challenging substrates. Learn how APExBIO’s high-purity reagent empowers complex molecule construction, with practical protocols, troubleshooting, and insights from recent breakthroughs.

• Nystatin (Fungicidin): Synergy, Resistance, and Research Fro

  2026-07-09

  Explore Nystatin (Fungicidin) as a polyene antifungal through the lens of synergy, resistance, and advanced research applications. This article uncovers new scientific insights and practical assay guidance for researchers.

• AMPK–SQSTM1 Feedback Loop Drives Dual Antioxidant Activation

  2026-07-08

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 during metabolic stress, resulting in synergistic activation of AMPK and NFE2L2/NRF2. These findings refine our understanding of metabolic adaptation in tumor cells and highlight actionable molecular targets for research into cancer metabolism and inflammation.

• T7 RNA Polymerase: Precision RNA Synthesis from E. coli Enzy

  2026-07-08

  APExBIO's T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, enables high-specificity in vitro transcription for applications ranging from RNA vaccine development to advanced RNAi research. This article unpacks experimental workflows, troubleshooting strategies, and the impact of cutting-edge studies on optimizing RNA synthesis for modern molecular biology.

• Lipid Composition Dictates mRNA Lipoplex Immunogenicity in M

  2026-07-07

  This study systematically evaluates how different cationic and neutral lipid combinations in mRNA lipoplexes influence antibody production and protein expression after systemic administration in mice. The findings offer mechanistic insight into mRNA vaccine carrier optimization and highlight key lipid formulations for enhanced immunogenicity and delivery.

• Protoporphyrin IX (SKU B8225): Reliable Workflows for Cell A

  2026-07-07

  This scenario-driven article demonstrates how Protoporphyrin IX (SKU B8225) from APExBIO enables robust, reproducible cell viability and ferroptosis assays in biomedical research. Addressing common laboratory challenges from protocol optimization to vendor selection, it provides practical guidance underpinned by recent literature and validated product data.

• Ionizing Radiation Alters Neural Differentiation via PI3K-ST

  2026-07-06

  This study reveals that ionizing radiation (IR) drives altered neuronal differentiation in C17.2 mouse neural stem-like cells through the PI3K-STAT3-mGluR1 axis. The findings highlight new mechanistic links between IR exposure and potential neural dysfunction, offering a rigorous model for exploring metabolic and epigenetic regulation during neural differentiation.

• GSK343: Precision EZH2 Inhibitor for Epigenetic Cancer Resea

  2026-07-06

  GSK343 stands out as a potent, selective tool for dissecting EZH2-driven epigenetic repression in cancer models. Its reproducible inhibition of histone H3K27 trimethylation enables robust, quantitative assays for tumor biology and immunogenicity. This article delivers advanced, actionable workflows, troubleshooting strategies, and translational insights to empower your research.

15152 records 1/1011 page Next 12345 下5页 Last page